Illumina stated that the abstract presentations are “overwhelming” in support of comprehensive genomic profiling testing for advanced cancer patients compared to standard chemotherapy, radiation or surgery.
The personal genetics company created a therapeutics group to extricate new drug targets from its research database.
Newly discovered ALS gene may lead to new drug targets
February 19, 2015
7:00 pm
A research collaboration between medical centers, drugmaker Biogen Idec and a biotechnology institute have identified a gene that could lead to new drug targets for sporadic amyotrophic lateral sclerosis—or Lou Gehrig’s disease.
Allergan inches closer to Valeant takeover; Mylan trials underway for Lantus biosimilar and generic Advair; FDA advisers to make decision tomorrow on whether testosterone products are being prescribed correctly and if the drugs’ label merits change.